What Researchers Did
Researchers reviewed the current advances and potential roles of various gas therapies, including nitric oxide, ozone, hyperbaric oxygen, hydrogen, and heliox, for treating severe COVID-19 and associated acute respiratory distress syndrome.
What They Found
The review found that various gas therapies, such as nitric oxide, ozone, hyperbaric oxygen, hydrogen, and heliox, have been employed in the fight against the COVID-19 pandemic. These therapies have shown improved clinical outcomes for patients suffering from severe COVID-19 and acute respiratory distress syndrome.
What This Means for Canadian Patients
Canadian patients with severe COVID-19 and acute respiratory distress syndrome may benefit from further research into these promising gas therapies. While these therapies show potential, their widespread use in Canada would require robust evidence from well-designed clinical trials.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients. However, the findings on potential COVID-19 treatments are globally relevant.
Study Limitations
A key limitation highlighted is the need for well-designed randomized controlled trials to verify the potential roles of these gas therapies in COVID-19 treatment.